Drug intelligence / Profile preview

Macrafol-FA

Development stage
Unknown
Lead developer
TCF Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Macrafol-FA is an oral nutritional supplement formulated as softgel capsules, developed and marketed by TCF Pharmaceuticals. It is a combination product containing ferrous ascorbate, folic acid, methylcobalamin, and adenosylcobalamin. It is primarily indicated for the management of anemia and nutritional support in gynecological care, including pregnancy. Ferrous ascorbate serves as a highly bioavailable source of iron to replenish hemoglobin levels. Folic acid (vitamin B9) is essential for DNA synthesis and red blood cell production, helping to prevent neural tube defects during pregnancy. Methylcobalamin and adenosylcobalamin are active coenzyme forms of vitamin B12 that support neurological function, myelin sheath maintenance, and mitochondrial energy metabolism.

Brand names
Macrafol-FA
Other names
ferrous ascorbate + folic acid + methylcobalamin + adenosylcobalaminferrous ascorbate/folic acid/methylcobalamin/adenosylcobalamin
02

Targets

DHFR (Dihydrofolate reductase)SLC11A2 (DMT1)FOLR1 (FRα)MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on Macrafol-FA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrafol-FA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call